Clinical trial · Observational
Impact of Serious Pediatric Illness on Parent and Sibling Health
NCT03971344CI-TRIAL-00046864completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To estimate the impact of having a child with serious illness (SI) on the health and healthcare of other members of the child's family.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Family Members of: Children Severe Neurological Impairment | — | UNRESOLVED | — |
| Family Members of: Critical Congenital Heart Defect Patients | — | UNRESOLVED | — |
| Family Members of: Newborns Extremely Premature | — | UNRESOLVED | — |
| Family Members of: New Pediatric Oncology Patients | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (4)
- label
- Family members of newborns extremely premature
- description
- Parents and siblings (if any) of infants born at 30 weeks gestational age or less, or with a birthweight less than 1500 grams.
- label
- Family members of new pediatric oncology patients
- description
- Parents and siblings (if any) of patients with new onset (not relapses) pediatric oncologic diagnoses including liquid, solid, and brain cancer.
- label
- Family members of critical congenital heart defect patients
- description
- Parents and siblings (if any) of newborns with critical congenital heart defects who typically undergo surgery by 12 months of life.
- label
- Family members of children with severe neurological impairment
- description
- Parents and siblings (if any) of patients with severe neurologic impairments, associated with substantial functional impairment, relentless progressive deterioration, or substantially shortened life-spans.
Primary outcomes (8)
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Cigna customers as follows: 1. Neonatal Intensive Care Unit (NICU) cohort: infants born at 30 weeks gestational age or less, or with a birthweight less than 1500 grams. 2. Critical Congenital Heart Disease (CCHD) cohort: Newborns with critical congenital heart defects who undergo surgery by 12 months of life. 3. Oncology cohort: Patients with new onset (not relapses) pediatric oncologic diagnoses including liquid, solid, and brain cancer. 4. Severe Neurological Impairment (NI) cohort: Patients with severe neurologic impairments, associated with substantial functional impairment, relentless progressive deterioration, or substantially shortened life-spans. * For each index patient in a particular SPI cohort, Investigators randomly identified up to four children of the same ages as the index patient but who do not have the specific SPI. The matching by age was as follows: in months if \< 3 years; and in years if age \> or = 3 years. Cigna then identified all family members, using both definitions of "family members" described above. Exclusion Criteria: \-
References
Publications (0)
Data not yet available
No reference posted for this study.